These data show the relevance of the NRG1–HER3 and FGF–FGFR1 compensatory mechanism in longitudinal samples, suggesting FGFR1 upregulation as a potential escape mechanism of BC cells that develop treatment resistance (Fig. 6j). This evidence concerns the gene NRG1 and breast cancer.